Volume 13, Issue 5, October 2013

ISSN: 1534-4827 (Print) 1539-0829 (Online)

In this issue (18 articles)

  1. No Access

    Pathogenesis of Type 1 Diabetes (D Dabelea, Section Editor)

    Human Intestinal Microbiota and Type 1 Diabetes

    Outi Vaarala Pages 601-607
  2. No Access

    Pathogenesis of Type 1 Diabetes (D Dabelea, Section Editor)

    Novel Diabetes Autoantibodies and Prediction of Type 1 Diabetes

    Janet M. Wenzlau, John C. Hutton Pages 608-615
  3. No Access

    Pathogenesis of Type 1 Diabetes (D Dabelea, Section Editor)

    Antigen-Based Vaccination and Prevention of Type 1 Diabetes

    Leonard C. Harrison, John M. Wentworth, Yuxia Zhang Pages 616-623
  4. No Access

    Pathogenesis of Type 1 Diabetes (D Dabelea, Section Editor)

    Epigenetic Regulation of Pancreatic Islets

    Cecile Haumaitre Pages 624-632
  5. No Access

    Pathogenesis of Type 1 Diabetes (D Dabelea, Section Editor)

    Is Autoimmunity or Insulin Resistance the Primary Driver of Type 1 Diabetes?

    Terence J. Wilkin Pages 651-656
  6. No Access

    Treatment of Type 1 Diabetes (JR Unger, Section Editor)

    Continuous Glucose Monitoring: Current Use and Future Directions

    Daniel DeSalvo, Bruce Buckingham Pages 657-662
  7. No Access

    Treatment of Type 1 Diabetes (JR Unger, Section Editor)

    Rationale Use of GLP-1 Receptor Agonists in Patients with Type 1 Diabetes

    Jeff Unger Pages 663-668